Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome.

The present document has been prepared by a group of experts, members of cardiology, endocrinology, internal medicine, nephrology and diabetes societies of Latin American countries, to serve as a guide to physicians taking care of patients with diabetes, hypertension and comorbidities or complications of both conditions. Although the concept of metabolic syndrome is currently disputed, the higher prevalence in Latin America of that cluster of metabolic alterations has suggested that metabolic syndrome is a useful nosography entity in the context of Latin American medicine. Therefore, in the present document, particular attention is paid to this syndrome in order to alert physicians on a particular high-risk population, usually underestimated and undertreated. These recommendations result from presentations and debates by discussion panels during a 2-day conference held in Bucaramanga, in October 2012, and all the participants have approved the final conclusions. The authors acknowledge that the publication and diffusion of guidelines do not suffice to achieve the recommended changes in diagnostic or therapeutic strategies, and plan suitable interventions overcoming knowledge, attitude and behavioural barriers, preventing both physicians and patients from effectively adhering to guideline recommendations.

[1]  Giuseppe Ambrosio,et al.  Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications , 2012, Hypertension.

[2]  Morris J. Brown,et al.  A Double-Blind, Placebo-Controlled, Crossover Trial Comparing the Effects of Amiloride and Hydrochlorothiazide on Glucose Tolerance in Patients With Essential Hypertension , 2012, Hypertension.

[3]  R. Wong,et al.  Coexistence of Obesity and Anemia in Older Mexican Adults , 2012, Ageing international.

[4]  M. Rutter,et al.  Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care. , 2011, European heart journal.

[5]  G. Mancia,et al.  Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.

[6]  S. Bangalore,et al.  Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials , 2011, Circulation.

[7]  F. Márquez-Sandoval,et al.  The prevalence of metabolic syndrome in Latin America: a systematic review , 2011, Public Health Nutrition.

[8]  P. López-Jaramillo,et al.  Epidemic of cardiometabolic diseases: a Latin American point of view , 2011, Therapeutic advances in cardiovascular disease.

[9]  S. Nesbitt,et al.  Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. , 2010, Hypertension.

[10]  G. Bakris,et al.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.

[11]  J. Lewis Blood pressure control in chronic kidney disease: is less really more? , 2010, Journal of the American Society of Nephrology : JASN.

[12]  M. Velasco,et al.  The Maracaibo city metabolic syndrome prevalence study: design and scope. , 2010, American journal of therapeutics.

[13]  C. Seas,et al.  Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[14]  A. AlShehri Metabolic syndrome and cardiovascular risk. , 2010, Journal of family & community medicine.

[15]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[16]  A. Dominiczak,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. , 2009, Journal of hypertension.

[17]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[18]  C. Boissonnet,et al.  Open Access Cardiovascular Diabetology Prevalence of the Metabolic Syndrome in Latin America and Its Association with Sub-clinical Carotid Atherosclerosis: the Carmela Cross Sectional Study , 2022 .

[19]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[20]  P. López-Jaramillo Cardiometabolic disease in latin america: the role of fetal programming in response to maternal malnutrition. , 2009, Revista espanola de cardiologia.

[21]  G. Mancia,et al.  When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.

[22]  M. Franco,et al.  Stunting growth: association of the blood pressure levels and ACE activity in early childhood , 2009, Pediatric Nephrology.

[23]  K. Arheart,et al.  Prevalence of Metabolic Syndrome in US-Born Latin and Caribbean Youth , 2009, Journal of Immigrant and Minority Health.

[24]  Giuseppe Mancia,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document , 2009, Blood pressure.

[25]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[26]  F. A. Moura,et al.  Short stature of mothers from an area endemic for undernutrition is associated with obesity, hypertension and stunted children: a population-based study in the semi-arid region of Alagoas, Northeast Brazil , 2008, British Journal of Nutrition.

[27]  P. López-Jaramillo Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. , 2008, Journal of hypertension.

[28]  S. Rodríguez,et al.  Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity , 2008, BMC pediatrics.

[29]  P. López-Jaramillo,et al.  Are Nutrition-Induced Epigenetic Changes the Link Between Socioeconomic Pathology and Cardiovascular Diseases? , 2008, American journal of therapeutics.

[30]  Yolanda Torres,et al.  Prevalencia y comportamiento de los factores de riesgo del síndrome metabólico según los diferentes intervalos de edad, en una población femenina del área de influencia de la Clínica Las Américas, en Medellín - Colombia , 2008 .

[31]  F. Manzur,et al.  Phenotypic and metabolic characterization of the metabolic syndrome in Cartagena de Indias , 2008 .

[32]  P. López-Jaramillo,et al.  Inter-relationships between body mass index, C-reactive protein and blood pressure in a Hispanic pediatric population. , 2008, American journal of hypertension.

[33]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[34]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[35]  Sabrina E. Noel,et al.  Metabolic Syndrome in Elderly Living in Marginal Peri‐Urban Communities in Quito, Ecuador , 2008, Public Health Nutrition.

[36]  D. Casarini,et al.  Circulating renin-angiotensin system and catecholamines in childhood: is there a role for birthweight? , 2008, Clinical science.

[37]  Executive Summary: Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[38]  A. Barcelo,et al.  Waist circumference, BMI and the prevalence of self-reported diabetes among the elderly of the United States and six cities of Latin America and the Caribbean. , 2007, Diabetes research and clinical practice.

[39]  Renke Maas,et al.  Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome. , 2007, International journal of cardiology.

[40]  H. Bettiol,et al.  Metabolic syndrome in young adults from two socioeconomic Latin American settings. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[41]  Eduardo Fasce,et al.  Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile , 2007, Journal of hypertension.

[42]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[43]  X. Rabasseda New joint European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. , 2007, Timely topics in medicine. Cardiovascular diseases.

[44]  P. Montoya SÍNDROME METABÓLICO EN UNA POBLACIÓN RURAL Y UNA POBLACIÓN URBANA DE LA REGIÓN ANDINA COLOMBIANA , 2007 .

[45]  J. Medina-Lezama,et al.  Prevalence and patterns of hypertension in Peruvian Andean Hispanics: the PREVENCION study. , 2007, Journal of the American Society of Hypertension : JASH.

[46]  P. López-Jaramillo,et al.  The utility of different definitions of metabolic syndrome in Andean population. , 2007, International journal of cardiology.

[47]  E. Kabagambe,et al.  Nonfatal Acute Myocardial Infarction in Costa Rica: Modifiable Risk Factors, Population-Attributable Risks, and Adherence to Dietary Guidelines , 2007, Circulation.

[48]  J. Blümel,et al.  The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women , 2007, Climacteric : the journal of the International Menopause Society.

[49]  P. López-Jaramillo,et al.  A proposal for an appropriate central obesity diagnosis in Latin American population. , 2006, International journal of cardiology.

[50]  C. Agusti Epidemiología de la Hipertensión Arterial en el Perú , 2006 .

[51]  V. Merchán Síndrome metabólico y riesgo de enfermedad cardiovascular , 2005 .

[52]  Barry R Davis,et al.  Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. , 2005, JAMA.

[53]  Neil Chapman,et al.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.

[54]  E. C. Moura,et al.  Socioeconomic status and obesity in adult populations of developing countries: a review. , 2004, Bulletin of the World Health Organization.

[55]  B. Popkin,et al.  Obesity and inequities in health in the developing world , 2004, International Journal of Obesity.

[56]  M. Stern,et al.  Secular trends in obesity in Mexico City and in San Antonio. , 2004, Nutrition reviews.

[57]  A. Dyer,et al.  Ethnic Differences in correlates of obesity between Latin-American and black Women. , 2004, Obesity research.

[58]  A. Sawaya,et al.  Short stature, obesity and arterial hypertension in a very low income population in North-eastern Brazil. , 2004, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[59]  D. Schriger,et al.  Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? , 2004, Diabetes care.

[60]  P. López-Jaramillo,et al.  Using waist circumference as a screening tool to identify colombian subjects at cardiovascular risk , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[61]  Á. Avezum,et al.  Risk factors for myocardial infarction in Brazil. , 2003, American heart journal.

[62]  C. Bouchard,et al.  Effect of malnutrition during the first year of life on adult plasma insulin and glucose tolerance. , 2003, Metabolism: clinical and experimental.

[63]  D. Bell Heart failure: the frequent, forgotten, and often fatal complication of diabetes. , 2003, Diabetes care.

[64]  G. Reaven,et al.  Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.

[65]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[66]  Yutaka Imai,et al.  European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.

[67]  G. Tognoni,et al.  Treatment and control of arterial hypertension in a rural community in Ecuador , 2003, The Lancet.

[68]  R. Sesso,et al.  Increased blood pressure in adolescents of low socioeconomic status with short stature , 2003, Pediatric Nephrology.

[69]  Kazuomi Kario,et al.  Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.

[70]  A. Tuttolomondo,et al.  Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. , 2003, Stroke.

[71]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[72]  G. Grunwald,et al.  Differences in resting metabolic rate between white and African-American young adults. , 2002, Obesity research.

[73]  R. Bonow,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications , 2002, Circulation.

[74]  S. Grundy,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association , 2002, Circulation.

[75]  G. Velásquez-Melendez,et al.  Evaluation of waist circumference to predict general obesity and arterial hypertension in women in Greater Metropolitan Belo Horizonte, Brazil. , 2002, Cadernos de saude publica.

[76]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[77]  S. Barreto,et al.  Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil--The Bambuí Health and Ageing Study. , 2001, Arquivos brasileiros de cardiologia.

[78]  A Berber,et al.  Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population , 2001, International Journal of Obesity.

[79]  J E Schwartz,et al.  Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives , 2001, Hypertension.

[80]  Claudio D. González,et al.  Obesity prevalence and trends in Latin‐American countries , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[81]  J. Staessen,et al.  Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. , 2001, Archives of internal medicine.

[82]  M. Onis,et al.  Prevalence and trends of overweight among preschool children in developing countries. , 2000, The American journal of clinical nutrition.

[83]  M. Rodríguez-Moran,et al.  Prevalence of hypertension in indigenous inhabitants of traditional communities from the north of Mexico , 2000, Journal of Human Hypertension.

[84]  R. Schrier,et al.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.

[85]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[86]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[87]  C. Rotimi,et al.  Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[88]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[89]  KlasMalmberg,et al.  Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction , 1999 .

[90]  K. Walker,et al.  Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. , 1999, Diabetes care.

[91]  C. Bulpitt,et al.  Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .

[92]  R J Shephard,et al.  Exercise as cardiovascular therapy. , 1999, Circulation.

[93]  J A Staessen,et al.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.

[94]  C. Szwarcwald,et al.  Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors – the Rio de Janeiro Study , 1998, Journal of hypertension.

[95]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[96]  L. Grummer-Strawn,et al.  Obesity in Latin American women and children. , 1998, The Journal of nutrition.

[97]  M. Rodríguez-Morán,et al.  Prevalencia de hipertensión arterial y factores asociados en la población rural marginada , 1998 .

[98]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[99]  L. Barriocanal,et al.  Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[100]  F. Nieto,et al.  Hypertension in Cuba: evidence of a narrow black–white difference , 1998, Journal of Human Hypertension.

[101]  Jenny Field,et al.  General practitioners' perceptions of the route to evidence based medicine: a questionnaire survey , 1998, BMJ.

[102]  L Guize,et al.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.

[103]  J. Colwell Aspirin Therapy in Diabetes , 1997, Diabetes Care.

[104]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[105]  B. Davis,et al.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.

[106]  W A Ray,et al.  Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema , 1996, Clinical pharmacology and therapeutics.

[107]  L. Bang,et al.  24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. , 1995, American journal of hypertension.

[108]  F. Port,et al.  The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[109]  T Delamothe,et al.  Wanted: guidelines that doctors will follow. , 1993, BMJ.

[110]  S. Woolf Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. , 1992, Archives of internal medicine.

[111]  W. McClellan,et al.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[112]  L. Tobian,et al.  Hypertension and obesity. , 1978, The New England journal of medicine.

[113]  N. Serrano,et al.  [Impact of the new definitions in the prevalence of the metabolic syndrome in an adult population at Bucaramanga, Colombia]. , 2007, Biomedica : revista del Instituto Nacional de Salud.

[114]  W. Elliott Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus: Results of Prospectively Designed Overviews of Randomized Trials , 2006 .

[115]  A. Tuttolomondo,et al.  Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. , 2005, Neurology.

[116]  Irene M Stratton,et al.  Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. , 2004, Diabetes care.

[117]  B. Jönsson Revealing the cost of Type II diabetes in Europe. , 2002, Diabetologia.

[118]  G. Bakris,et al.  SPECIAL REPORT Preserving Renal Function in Adults With Hypertension and Diabetes: A Consensus Approach , 2000 .

[119]  C. Bulpitt,et al.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. , 1999, The New England journal of medicine.

[120]  E. O’Brien,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.

[121]  American College of Sports Medicine and American Diabetes Association joint position statement. Diabetes mellitus and exercise. , 1997, Medicine and science in sports and exercise.

[122]  R. DeFronzo Diabetic nephropathy: Etiologic and therapeutic considerations , 1995 .

[123]  P. Savage,et al.  Correlates of obesity in young black and white women: the CARDIA Study. , 1992, American journal of public health.

[124]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[125]  G. Duvel The study group. , 1980 .